KLINGENSTEIN FIELDS & CO LP - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 97 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.57 and the average weighting 1.0%.

Quarter-by-quarter ownership
KLINGENSTEIN FIELDS & CO LP ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$51,000
+4.1%
10,6180.0%0.00%0.0%
Q2 2021$49,000
-21.0%
10,6180.0%0.00%
-33.3%
Q1 2021$62,000
+72.2%
10,6180.0%0.00%
+50.0%
Q4 2020$36,000
+140.0%
10,6180.0%0.00%
+100.0%
Q3 2020$15,000
-28.6%
10,6180.0%0.00%0.0%
Q2 2020$21,0000.0%10,6180.0%0.00%0.0%
Q1 2020$21,000
-52.3%
10,6180.0%0.00%
-50.0%
Q4 2019$44,000
+37.5%
10,6180.0%0.00%0.0%
Q3 2019$32,000
-52.2%
10,6180.0%0.00%
-33.3%
Q2 2019$67,000
+13.6%
10,6180.0%0.00%0.0%
Q1 2019$59,000
-16.9%
10,6180.0%0.00%0.0%
Q4 2018$71,000
-37.2%
10,6180.0%0.00%
-25.0%
Q3 2018$113,000
-11.0%
10,6180.0%0.00%
-20.0%
Q2 2018$127,000
+39.6%
10,6180.0%0.01%
+66.7%
Q1 2018$91,000
-13.3%
10,6180.0%0.00%
-25.0%
Q4 2017$105,000
-37.1%
10,618
-22.0%
0.00%
-33.3%
Q3 2017$167,000
-25.4%
13,6180.0%0.01%
-33.3%
Q2 2017$224,000
+4.7%
13,618
-8.6%
0.01%0.0%
Q1 2017$214,000
+3.9%
14,9030.0%0.01%0.0%
Q4 2016$206,000
-23.4%
14,9030.0%0.01%
-25.0%
Q3 2016$269,000
+25.7%
14,9030.0%0.01%
+20.0%
Q2 2016$214,000
+20.2%
14,9030.0%0.01%
+11.1%
Q1 2016$178,000
-10.1%
14,9030.0%0.01%
-10.0%
Q4 2015$198,000
+23.8%
14,9030.0%0.01%
+25.0%
Q3 2015$160,00014,9030.01%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$25,366,000100.00%
Artal Group S.A. 71,178,364$417,817,0007.38%
BVF INC/IL 8,394,000$49,273,0001.85%
Boothe Investment Group, Inc. 435,939$2,559,0001.49%
Campbell & CO Investment Adviser LLC 103,100$605,0000.37%
NEA Management Company, LLC 2,382,286$13,984,0000.31%
PINNACLE ASSOCIATES LTD 2,167,172$12,721,0000.24%
Eversept Partners, LP 410,593$2,410,1810.18%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$210,0000.12%
OCCUDO QUANTITATIVE STRATEGIES LP 66,299$389,0000.08%
View complete list of LEXICON PHARMACEUTICALS INC shareholders